Medical Care
Global Placental Stem Cell Therapy for Neurological Disorders Market Research Report 2023
- Jan 18, 24
- ID: 2443
- Pages: 85
- Figures: 163
- Views: 48
Placental stem cell therapy for neurological disorders involves the use of stem cells derived from the placenta to treat conditions affecting the nervous system. These cells have the potential to differentiate into various specialized cell types, promoting neural regeneration and repair. This therapeutic approach aims to address conditions like Parkinson's disease, Alzheimer's, and spinal cord injuries, offering a promising avenue for regenerative medicine in neurology by harnessing the regenerative capabilities of placental-derived stem cells.
According to HengCe’s new survey, global Placental Stem Cell Therapy for Neurological Disorders market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
The industry trend for placental stem cell therapy in neurological disorders is marked by ongoing research and clinical trials to explore its efficacy and safety. As advancements in stem cell technology and understanding of neurobiology progress, there's a growing interest in developing targeted and personalized therapies. Regulatory frameworks are evolving to accommodate these innovative treatments. The trend also involves collaborations between academia, biotech companies, and healthcare institutions to accelerate the translation of research findings into practical and accessible therapeutic solutions, reflecting a positive outlook for the integration of placental stem cell therapy into neurological care.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Placental Stem Cell Therapy for Neurological Disorders market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Mesoblast
Pleurite Therapeutic
Athersys
Cordlife India
Life Cell
Cryo-Cell
CBR Systems
ReNeuron Group
Cynata
Celularity
Americord Registry
ReeLabs
Mesoblast
Segment by Type
Allogeneic Placental Stem Cell Therapy
Autologous Placental Stem Cell Therapy
Segment by Application
Hospitals and Specialist Clinics
Clinical Research Institute
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Placental Stem Cell Therapy for Neurological Disorders report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to HengCe’s new survey, global Placental Stem Cell Therapy for Neurological Disorders market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
The industry trend for placental stem cell therapy in neurological disorders is marked by ongoing research and clinical trials to explore its efficacy and safety. As advancements in stem cell technology and understanding of neurobiology progress, there's a growing interest in developing targeted and personalized therapies. Regulatory frameworks are evolving to accommodate these innovative treatments. The trend also involves collaborations between academia, biotech companies, and healthcare institutions to accelerate the translation of research findings into practical and accessible therapeutic solutions, reflecting a positive outlook for the integration of placental stem cell therapy into neurological care.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Placental Stem Cell Therapy for Neurological Disorders market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Mesoblast
Pleurite Therapeutic
Athersys
Cordlife India
Life Cell
Cryo-Cell
CBR Systems
ReNeuron Group
Cynata
Celularity
Americord Registry
ReeLabs
Mesoblast
Segment by Type
Allogeneic Placental Stem Cell Therapy
Autologous Placental Stem Cell Therapy
Segment by Application
Hospitals and Specialist Clinics
Clinical Research Institute
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Placental Stem Cell Therapy for Neurological Disorders report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Allogeneic Placental Stem Cell Therapy
1.2.3 Autologous Placental Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals and Specialist Clinics
1.3.3 Clinical Research Institute
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Perspective (2018-2029)
2.2 Placental Stem Cell Therapy for Neurological Disorders Growth Trends by Region
2.2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Region (2018-2023)
2.2.3 Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Region (2024-2029)
2.3 Placental Stem Cell Therapy for Neurological Disorders Market Dynamics
2.3.1 Placental Stem Cell Therapy for Neurological Disorders Industry Trends
2.3.2 Placental Stem Cell Therapy for Neurological Disorders Market Drivers
2.3.3 Placental Stem Cell Therapy for Neurological Disorders Market Challenges
2.3.4 Placental Stem Cell Therapy for Neurological Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Revenue
3.1.1 Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Revenue (2018-2023)
3.1.2 Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Players (2018-2023)
3.2 Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Placental Stem Cell Therapy for Neurological Disorders Revenue
3.4 Global Placental Stem Cell Therapy for Neurological Disorders Market Concentration Ratio
3.4.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Placental Stem Cell Therapy for Neurological Disorders Revenue in 2022
3.5 Placental Stem Cell Therapy for Neurological Disorders Key Players Head office and Area Served
3.6 Key Players Placental Stem Cell Therapy for Neurological Disorders Product Solution and Service
3.7 Date of Enter into Placental Stem Cell Therapy for Neurological Disorders Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Placental Stem Cell Therapy for Neurological Disorders Breakdown Data by Type
4.1 Global Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Type (2018-2023)
4.2 Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Type (2024-2029)
5 Placental Stem Cell Therapy for Neurological Disorders Breakdown Data by Application
5.1 Global Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Application (2018-2023)
5.2 Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
6.2 North America Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023)
6.4 North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
7.2 Europe Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023)
7.4 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
8.2 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2018-2023)
8.4 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
9.2 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023)
9.4 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
10.2 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023)
10.4 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mesoblast
11.1.1 Mesoblast Company Detail
11.1.2 Mesoblast Business Overview
11.1.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Introduction
11.1.4 Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.1.5 Mesoblast Recent Development
11.2 Pleurite Therapeutic
11.2.1 Pleurite Therapeutic Company Detail
11.2.2 Pleurite Therapeutic Business Overview
11.2.3 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Introduction
11.2.4 Pleurite Therapeutic Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.2.5 Pleurite Therapeutic Recent Development
11.3 Athersys
11.3.1 Athersys Company Detail
11.3.2 Athersys Business Overview
11.3.3 Athersys Placental Stem Cell Therapy for Neurological Disorders Introduction
11.3.4 Athersys Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.3.5 Athersys Recent Development
11.4 Cordlife India
11.4.1 Cordlife India Company Detail
11.4.2 Cordlife India Business Overview
11.4.3 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Introduction
11.4.4 Cordlife India Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.4.5 Cordlife India Recent Development
11.5 Life Cell
11.5.1 Life Cell Company Detail
11.5.2 Life Cell Business Overview
11.5.3 Life Cell Placental Stem Cell Therapy for Neurological Disorders Introduction
11.5.4 Life Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.5.5 Life Cell Recent Development
11.6 Cryo-Cell
11.6.1 Cryo-Cell Company Detail
11.6.2 Cryo-Cell Business Overview
11.6.3 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Introduction
11.6.4 Cryo-Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.6.5 Cryo-Cell Recent Development
11.7 CBR Systems
11.7.1 CBR Systems Company Detail
11.7.2 CBR Systems Business Overview
11.7.3 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Introduction
11.7.4 CBR Systems Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.7.5 CBR Systems Recent Development
11.8 ReNeuron Group
11.8.1 ReNeuron Group Company Detail
11.8.2 ReNeuron Group Business Overview
11.8.3 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Introduction
11.8.4 ReNeuron Group Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.8.5 ReNeuron Group Recent Development
11.9 Cynata
11.9.1 Cynata Company Detail
11.9.2 Cynata Business Overview
11.9.3 Cynata Placental Stem Cell Therapy for Neurological Disorders Introduction
11.9.4 Cynata Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.9.5 Cynata Recent Development
11.10 Celularity
11.10.1 Celularity Company Detail
11.10.2 Celularity Business Overview
11.10.3 Celularity Placental Stem Cell Therapy for Neurological Disorders Introduction
11.10.4 Celularity Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.10.5 Celularity Recent Development
11.11 Americord Registry
11.11.1 Americord Registry Company Detail
11.11.2 Americord Registry Business Overview
11.11.3 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Introduction
11.11.4 Americord Registry Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.11.5 Americord Registry Recent Development
11.12 ReeLabs
11.12.1 ReeLabs Company Detail
11.12.2 ReeLabs Business Overview
11.12.3 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Introduction
11.12.4 ReeLabs Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.12.5 ReeLabs Recent Development
11.13 Mesoblast
11.13.1 Mesoblast Company Detail
11.13.2 Mesoblast Business Overview
11.13.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Introduction
11.13.4 Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.13.5 Mesoblast Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Allogeneic Placental Stem Cell Therapy
1.2.3 Autologous Placental Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals and Specialist Clinics
1.3.3 Clinical Research Institute
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Perspective (2018-2029)
2.2 Placental Stem Cell Therapy for Neurological Disorders Growth Trends by Region
2.2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Region (2018-2023)
2.2.3 Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Region (2024-2029)
2.3 Placental Stem Cell Therapy for Neurological Disorders Market Dynamics
2.3.1 Placental Stem Cell Therapy for Neurological Disorders Industry Trends
2.3.2 Placental Stem Cell Therapy for Neurological Disorders Market Drivers
2.3.3 Placental Stem Cell Therapy for Neurological Disorders Market Challenges
2.3.4 Placental Stem Cell Therapy for Neurological Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Revenue
3.1.1 Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Revenue (2018-2023)
3.1.2 Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Players (2018-2023)
3.2 Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Placental Stem Cell Therapy for Neurological Disorders Revenue
3.4 Global Placental Stem Cell Therapy for Neurological Disorders Market Concentration Ratio
3.4.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Placental Stem Cell Therapy for Neurological Disorders Revenue in 2022
3.5 Placental Stem Cell Therapy for Neurological Disorders Key Players Head office and Area Served
3.6 Key Players Placental Stem Cell Therapy for Neurological Disorders Product Solution and Service
3.7 Date of Enter into Placental Stem Cell Therapy for Neurological Disorders Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Placental Stem Cell Therapy for Neurological Disorders Breakdown Data by Type
4.1 Global Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Type (2018-2023)
4.2 Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Type (2024-2029)
5 Placental Stem Cell Therapy for Neurological Disorders Breakdown Data by Application
5.1 Global Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Application (2018-2023)
5.2 Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
6.2 North America Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023)
6.4 North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
7.2 Europe Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023)
7.4 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
8.2 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2018-2023)
8.4 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
9.2 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023)
9.4 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size (2018-2029)
10.2 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023)
10.4 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mesoblast
11.1.1 Mesoblast Company Detail
11.1.2 Mesoblast Business Overview
11.1.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Introduction
11.1.4 Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.1.5 Mesoblast Recent Development
11.2 Pleurite Therapeutic
11.2.1 Pleurite Therapeutic Company Detail
11.2.2 Pleurite Therapeutic Business Overview
11.2.3 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Introduction
11.2.4 Pleurite Therapeutic Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.2.5 Pleurite Therapeutic Recent Development
11.3 Athersys
11.3.1 Athersys Company Detail
11.3.2 Athersys Business Overview
11.3.3 Athersys Placental Stem Cell Therapy for Neurological Disorders Introduction
11.3.4 Athersys Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.3.5 Athersys Recent Development
11.4 Cordlife India
11.4.1 Cordlife India Company Detail
11.4.2 Cordlife India Business Overview
11.4.3 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Introduction
11.4.4 Cordlife India Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.4.5 Cordlife India Recent Development
11.5 Life Cell
11.5.1 Life Cell Company Detail
11.5.2 Life Cell Business Overview
11.5.3 Life Cell Placental Stem Cell Therapy for Neurological Disorders Introduction
11.5.4 Life Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.5.5 Life Cell Recent Development
11.6 Cryo-Cell
11.6.1 Cryo-Cell Company Detail
11.6.2 Cryo-Cell Business Overview
11.6.3 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Introduction
11.6.4 Cryo-Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.6.5 Cryo-Cell Recent Development
11.7 CBR Systems
11.7.1 CBR Systems Company Detail
11.7.2 CBR Systems Business Overview
11.7.3 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Introduction
11.7.4 CBR Systems Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.7.5 CBR Systems Recent Development
11.8 ReNeuron Group
11.8.1 ReNeuron Group Company Detail
11.8.2 ReNeuron Group Business Overview
11.8.3 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Introduction
11.8.4 ReNeuron Group Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.8.5 ReNeuron Group Recent Development
11.9 Cynata
11.9.1 Cynata Company Detail
11.9.2 Cynata Business Overview
11.9.3 Cynata Placental Stem Cell Therapy for Neurological Disorders Introduction
11.9.4 Cynata Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.9.5 Cynata Recent Development
11.10 Celularity
11.10.1 Celularity Company Detail
11.10.2 Celularity Business Overview
11.10.3 Celularity Placental Stem Cell Therapy for Neurological Disorders Introduction
11.10.4 Celularity Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.10.5 Celularity Recent Development
11.11 Americord Registry
11.11.1 Americord Registry Company Detail
11.11.2 Americord Registry Business Overview
11.11.3 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Introduction
11.11.4 Americord Registry Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.11.5 Americord Registry Recent Development
11.12 ReeLabs
11.12.1 ReeLabs Company Detail
11.12.2 ReeLabs Business Overview
11.12.3 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Introduction
11.12.4 ReeLabs Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.12.5 ReeLabs Recent Development
11.13 Mesoblast
11.13.1 Mesoblast Company Detail
11.13.2 Mesoblast Business Overview
11.13.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Introduction
11.13.4 Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
11.13.5 Mesoblast Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Allogeneic Placental Stem Cell Therapy
Table 3. Key Players of Autologous Placental Stem Cell Therapy
Table 4. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2018-2023)
Table 8. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2024-2029)
Table 10. Placental Stem Cell Therapy for Neurological Disorders Market Trends
Table 11. Placental Stem Cell Therapy for Neurological Disorders Market Drivers
Table 12. Placental Stem Cell Therapy for Neurological Disorders Market Challenges
Table 13. Placental Stem Cell Therapy for Neurological Disorders Market Restraints
Table 14. Global Placental Stem Cell Therapy for Neurological Disorders Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Players (2018-2023)
Table 16. Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy for Neurological Disorders as of 2022)
Table 17. Ranking of Global Top Placental Stem Cell Therapy for Neurological Disorders Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Placental Stem Cell Therapy for Neurological Disorders Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Placental Stem Cell Therapy for Neurological Disorders Product Solution and Service
Table 21. Date of Enter into Placental Stem Cell Therapy for Neurological Disorders Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Type (2018-2023)
Table 25. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Type (2024-2029)
Table 27. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Application (2018-2023)
Table 29. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Application (2024-2029)
Table 31. North America Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029) & (US$ Million)
Table 46. Mesoblast Company Detail
Table 47. Mesoblast Business Overview
Table 48. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product
Table 49. Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 50. Mesoblast Recent Development
Table 51. Pleurite Therapeutic Company Detail
Table 52. Pleurite Therapeutic Business Overview
Table 53. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product
Table 54. Pleurite Therapeutic Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 55. Pleurite Therapeutic Recent Development
Table 56. Athersys Company Detail
Table 57. Athersys Business Overview
Table 58. Athersys Placental Stem Cell Therapy for Neurological Disorders Product
Table 59. Athersys Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 60. Athersys Recent Development
Table 61. Cordlife India Company Detail
Table 62. Cordlife India Business Overview
Table 63. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product
Table 64. Cordlife India Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 65. Cordlife India Recent Development
Table 66. Life Cell Company Detail
Table 67. Life Cell Business Overview
Table 68. Life Cell Placental Stem Cell Therapy for Neurological Disorders Product
Table 69. Life Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 70. Life Cell Recent Development
Table 71. Cryo-Cell Company Detail
Table 72. Cryo-Cell Business Overview
Table 73. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product
Table 74. Cryo-Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 75. Cryo-Cell Recent Development
Table 76. CBR Systems Company Detail
Table 77. CBR Systems Business Overview
Table 78. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product
Table 79. CBR Systems Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 80. CBR Systems Recent Development
Table 81. ReNeuron Group Company Detail
Table 82. ReNeuron Group Business Overview
Table 83. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product
Table 84. ReNeuron Group Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 85. ReNeuron Group Recent Development
Table 86. Cynata Company Detail
Table 87. Cynata Business Overview
Table 88. Cynata Placental Stem Cell Therapy for Neurological Disorders Product
Table 89. Cynata Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 90. Cynata Recent Development
Table 91. Celularity Company Detail
Table 92. Celularity Business Overview
Table 93. Celularity Placental Stem Cell Therapy for Neurological Disorders Product
Table 94. Celularity Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 95. Celularity Recent Development
Table 96. Americord Registry Company Detail
Table 97. Americord Registry Business Overview
Table 98. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product
Table 99. Americord Registry Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 100. Americord Registry Recent Development
Table 101. ReeLabs Company Detail
Table 102. ReeLabs Business Overview
Table 103. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product
Table 104. ReeLabs Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 105. ReeLabs Recent Development
Table 106. Mesoblast Company Detail
Table 107. Mesoblast Business Overview
Table 108. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product
Table 109. Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 110. Mesoblast Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Type: 2022 VS 2029
Figure 3. Allogeneic Placental Stem Cell Therapy Features
Figure 4. Autologous Placental Stem Cell Therapy Features
Figure 5. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Application: 2022 VS 2029
Figure 7. Hospitals and Specialist Clinics Case Studies
Figure 8. Clinical Research Institute Case Studies
Figure 9. Placental Stem Cell Therapy for Neurological Disorders Report Years Considered
Figure 10. Global Placental Stem Cell Therapy for Neurological Disorders Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Placental Stem Cell Therapy for Neurological Disorders Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region: 2022 VS 2029
Figure 13. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Players in 2022
Figure 14. Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy for Neurological Disorders as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Placental Stem Cell Therapy for Neurological Disorders Revenue in 2022
Figure 16. North America Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2018-2029)
Figure 18. United States Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2018-2029)
Figure 22. Germany Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2018-2029)
Figure 30. China Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2018-2029)
Figure 38. Mexico Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2018-2029)
Figure 42. Turkey Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Mesoblast Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 45. Pleurite Therapeutic Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 46. Athersys Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 47. Cordlife India Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 48. Life Cell Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 49. Cryo-Cell Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 50. CBR Systems Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 51. ReNeuron Group Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 52. Cynata Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 53. Celularity Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 54. Americord Registry Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 55. ReeLabs Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 56. Mesoblast Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Allogeneic Placental Stem Cell Therapy
Table 3. Key Players of Autologous Placental Stem Cell Therapy
Table 4. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2018-2023)
Table 8. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2024-2029)
Table 10. Placental Stem Cell Therapy for Neurological Disorders Market Trends
Table 11. Placental Stem Cell Therapy for Neurological Disorders Market Drivers
Table 12. Placental Stem Cell Therapy for Neurological Disorders Market Challenges
Table 13. Placental Stem Cell Therapy for Neurological Disorders Market Restraints
Table 14. Global Placental Stem Cell Therapy for Neurological Disorders Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Players (2018-2023)
Table 16. Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy for Neurological Disorders as of 2022)
Table 17. Ranking of Global Top Placental Stem Cell Therapy for Neurological Disorders Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Placental Stem Cell Therapy for Neurological Disorders Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Placental Stem Cell Therapy for Neurological Disorders Product Solution and Service
Table 21. Date of Enter into Placental Stem Cell Therapy for Neurological Disorders Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Type (2018-2023)
Table 25. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Type (2024-2029)
Table 27. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Application (2018-2023)
Table 29. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Application (2024-2029)
Table 31. North America Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2024-2029) & (US$ Million)
Table 46. Mesoblast Company Detail
Table 47. Mesoblast Business Overview
Table 48. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product
Table 49. Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 50. Mesoblast Recent Development
Table 51. Pleurite Therapeutic Company Detail
Table 52. Pleurite Therapeutic Business Overview
Table 53. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product
Table 54. Pleurite Therapeutic Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 55. Pleurite Therapeutic Recent Development
Table 56. Athersys Company Detail
Table 57. Athersys Business Overview
Table 58. Athersys Placental Stem Cell Therapy for Neurological Disorders Product
Table 59. Athersys Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 60. Athersys Recent Development
Table 61. Cordlife India Company Detail
Table 62. Cordlife India Business Overview
Table 63. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product
Table 64. Cordlife India Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 65. Cordlife India Recent Development
Table 66. Life Cell Company Detail
Table 67. Life Cell Business Overview
Table 68. Life Cell Placental Stem Cell Therapy for Neurological Disorders Product
Table 69. Life Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 70. Life Cell Recent Development
Table 71. Cryo-Cell Company Detail
Table 72. Cryo-Cell Business Overview
Table 73. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product
Table 74. Cryo-Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 75. Cryo-Cell Recent Development
Table 76. CBR Systems Company Detail
Table 77. CBR Systems Business Overview
Table 78. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product
Table 79. CBR Systems Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 80. CBR Systems Recent Development
Table 81. ReNeuron Group Company Detail
Table 82. ReNeuron Group Business Overview
Table 83. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product
Table 84. ReNeuron Group Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 85. ReNeuron Group Recent Development
Table 86. Cynata Company Detail
Table 87. Cynata Business Overview
Table 88. Cynata Placental Stem Cell Therapy for Neurological Disorders Product
Table 89. Cynata Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 90. Cynata Recent Development
Table 91. Celularity Company Detail
Table 92. Celularity Business Overview
Table 93. Celularity Placental Stem Cell Therapy for Neurological Disorders Product
Table 94. Celularity Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 95. Celularity Recent Development
Table 96. Americord Registry Company Detail
Table 97. Americord Registry Business Overview
Table 98. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product
Table 99. Americord Registry Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 100. Americord Registry Recent Development
Table 101. ReeLabs Company Detail
Table 102. ReeLabs Business Overview
Table 103. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product
Table 104. ReeLabs Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 105. ReeLabs Recent Development
Table 106. Mesoblast Company Detail
Table 107. Mesoblast Business Overview
Table 108. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product
Table 109. Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023) & (US$ Million)
Table 110. Mesoblast Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Type: 2022 VS 2029
Figure 3. Allogeneic Placental Stem Cell Therapy Features
Figure 4. Autologous Placental Stem Cell Therapy Features
Figure 5. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Application: 2022 VS 2029
Figure 7. Hospitals and Specialist Clinics Case Studies
Figure 8. Clinical Research Institute Case Studies
Figure 9. Placental Stem Cell Therapy for Neurological Disorders Report Years Considered
Figure 10. Global Placental Stem Cell Therapy for Neurological Disorders Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Placental Stem Cell Therapy for Neurological Disorders Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region: 2022 VS 2029
Figure 13. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Players in 2022
Figure 14. Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy for Neurological Disorders as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Placental Stem Cell Therapy for Neurological Disorders Revenue in 2022
Figure 16. North America Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2018-2029)
Figure 18. United States Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2018-2029)
Figure 22. Germany Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2018-2029)
Figure 30. China Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2018-2029)
Figure 38. Mexico Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2018-2029)
Figure 42. Turkey Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Mesoblast Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 45. Pleurite Therapeutic Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 46. Athersys Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 47. Cordlife India Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 48. Life Cell Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 49. Cryo-Cell Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 50. CBR Systems Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 51. ReNeuron Group Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 52. Cynata Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 53. Celularity Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 54. Americord Registry Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 55. ReeLabs Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 56. Mesoblast Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232